Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander Veldhuyzen van Zanten

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Reviews in Gastroenterological Disorders|May 31, 2003
Diagnosing irritable bowel syndromeSander Veldhuyzen van Zanten
Annals of Internal Medicine|July 1, 2024
In grade C/D erosive esophagitis, vonoprazan ranks highest among PPIs and P-CABs for healing and maintaining remissionSander Veldhuyzen van Zanten
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|May 17, 2007
A meta-analysis of the success rate of Helicobacter pylori therapy in CanadaChristopher Rodgers, Sander Veldhuyzen van Zanten
The American Journal of Gastroenterology|July 26, 2006
Should the presence of polymorphisms of CYP2C19 enzymes influence the choice of the proton pump inhibitor for treatment of Helicobacter pylori infection?Sander Veldhuyzen van Zanten, Kara Thompson
Annals of Internal Medicine|February 5, 2024
Biomarker risk assessment model identified high-risk patients with cancer who benefit from thromboprophylaxisSander Veldhuyzen van Zanten, Bruce Ritchie
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|August 12, 2009
Pancreatic cancer in Canada: incidence and mortality trends from 1992 to 2005Robert Flook, Sander Veldhuyzen van Zanten
Annals of Internal Medicine|September 2, 2024
A next-generation mt-sDNA test had 94% sensitivity for colorectal cancer and 91% specificity for advanced neoplasiaSander Veldhuyzen van Zanten, Ernst J Kuipers
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 8, 2003
What are the global response rates to Helicobacter pylori eradication therapy?Christopher Nash, Lori Fischbach, Sander Veldhuyzen van Zanten
Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal|June 16, 2011
Does the evidence show that prokinetic agents are effective in healing esophagitis and improving symptoms of GERD?Mirjam Looijer-van Langen, Sander Veldhuyzen van Zanten
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Safety and Efficacy of Single-Operator Cholangioscopy in the Treatment of Difficult Common Bile Duct Stones after Failed Conventional ERCPJaskiran Sandha, Sander Veldhuyzen van Zanten, Gurpal Sandha
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Reviews in Gastroenterological Disorders|May 31, 2003
Diagnosing irritable bowel syndromeSander Veldhuyzen van Zanten
Annals of Internal Medicine|July 1, 2024
In grade C/D erosive esophagitis, vonoprazan ranks highest among PPIs and P-CABs for healing and maintaining remissionSander Veldhuyzen van Zanten
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|May 17, 2007
A meta-analysis of the success rate of Helicobacter pylori therapy in CanadaChristopher Rodgers, Sander Veldhuyzen van Zanten
The American Journal of Gastroenterology|July 26, 2006
Should the presence of polymorphisms of CYP2C19 enzymes influence the choice of the proton pump inhibitor for treatment of Helicobacter pylori infection?Sander Veldhuyzen van Zanten, Kara Thompson
Annals of Internal Medicine|February 5, 2024
Biomarker risk assessment model identified high-risk patients with cancer who benefit from thromboprophylaxisSander Veldhuyzen van Zanten, Bruce Ritchie
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|August 12, 2009
Pancreatic cancer in Canada: incidence and mortality trends from 1992 to 2005Robert Flook, Sander Veldhuyzen van Zanten
Annals of Internal Medicine|September 2, 2024
A next-generation mt-sDNA test had 94% sensitivity for colorectal cancer and 91% specificity for advanced neoplasiaSander Veldhuyzen van Zanten, Ernst J Kuipers
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 8, 2003
What are the global response rates to Helicobacter pylori eradication therapy?Christopher Nash, Lori Fischbach, Sander Veldhuyzen van Zanten
Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal|June 16, 2011
Does the evidence show that prokinetic agents are effective in healing esophagitis and improving symptoms of GERD?Mirjam Looijer-van Langen, Sander Veldhuyzen van Zanten
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Safety and Efficacy of Single-Operator Cholangioscopy in the Treatment of Difficult Common Bile Duct Stones after Failed Conventional ERCPJaskiran Sandha, Sander Veldhuyzen van Zanten, Gurpal Sandha
Pageof 9